KIF4A promotes the development of bladder cancer by transcriptionally activating the expression of CDCA3

Mostrar otras versiones (1)

Bladder cancer (BC) is among the most common urinary system tumors with a high morbidity and mortality worldwide. Despite advancements being made in the diagnosis and treatment of bladder cancer, targeted therapy remains the most promising treatment, and novel therapeutic targets are urgently requir...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Pengyi, Wu, Kaijie, Gao, Zhongwei, Li, Huibing, Li, Wensheng, Wang, Xiaohui, Shi, Zhenguo, Xiao, Fei, Wang, Kaixuan, Li, Zhijun, Han, Qingjiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041479/
https://www.ncbi.nlm.nih.gov/pubmed/33846765
http://dx.doi.org/10.3892/ijmm.2021.4932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041479/
https://www.ncbi.nlm.nih.gov/pubmed/33846765
http://dx.doi.org/10.3892/ijmm.2021.4932

Ejemplares similares